John Emswiler - Concepedia

Concepedia

Author

John Emswiler

Bristol-Myers Squibb (United States)

Also Known As

J E Emswiler, J. E. Emswiler, J. EMSWILER, J. Emswiler, John E. Emswiler, John Emswiler

14

Publications

2.1K

Citations

11

H-Index

45

Concepts

All Affiliations

Bristol-Myers Squibb (United States)University of Washington Bristol-Myers Squibb (Germany)Emory University

JE

About

John Emswiler is an author at Bristol-Myers Squibb (United States) specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	936
2	Engineering	2	2	239
3	Natural Sciences	1	1	69
4	Allergy	1	1	787
5	Biochemistry	1	1	69

John Emswiler

×

11

Publications

2.1K

Citations

11

H-Index

	Year	Citations
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses Walter W. Shuford, Kerry Klussman, Douglas D. Tritchler, The Journal of Experimental Medicine Adaptive Immune SystemT-regulatory CellImmunologyImmunologic MechanismAntigen Processing	1997	787
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties Christian P. Larsen, Thomas C. Pearson, Andrew Adams, American Journal of Transplantation	2005	707
Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions JoAnne L. Greene, Gina Leytze, John Emswiler, Journal of Biological Chemistry	1996	232
Synthesis of nonionic gadolinium chelates useful as contrast agents for magnetic resonance imaging: 1,4,7-tris(carboxymethyl)-10-substituted-1,4,7,10-tetraazacyclododecanes and their corresponding gadolinium chelates Douglas D. Dischino, Edward J. Delaney, John Emswiler, Inorganic Chemistry Contrast AgentsEngineeringImaging AgentAltmetric Attention ScoreOrganic Chemistry	1991	146
Synthesis, characterization, and crystal structure of the gadolinium(III) chelate of (1R,4R,7R)-.alpha.,.alpha.',.alpha.''-trimethyl-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (DO3MA) Sang Ihn Kang, Rama S. Ranganathan, John Emswiler, Inorganic Chemistry Materials ScienceCrystal Structure-Trimethyl-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic AcidEngineeringAltmetric Attention Score	1993	93
Identification of Amino Acid Residues Important for Ligand Binding to Fas Gary C. Starling, Jürgen Bajorath, John Emswiler, The Journal of Experimental Medicine Fas-fasl InteractionProtein AssemblyApoptosisImmune RegulationImmunology	1997	69
In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates. H P Svensson, Vivekananda M. Vrudhula, John Emswiler, PubMed ImmunologyImmunoeditingAntimicrobial ChemotherapyImmunotherapyTumor Biology	1995	41
Recognition of Diverse Proteins by Members of the Immunoglobulin Superfamily: Delineation of the Receptor Binding Site in the Human CD6 Ligand ALCAM John E. Skonier, Michael A. Bowen, John Emswiler, Biochemistry Igsf Cell SurfaceImmunologyImmune RegulationMolecular BiologyImmunologic Mechanism	1996	20
Mutational analysis of the CD6 ligand binding domain John E. Skonier, Dale L. Bodian, John Emswiler, Protein Engineering Design and Selection Cell AdhesionImmune RegulationImmunologyMolecular BiologyImmunologic Mechanism	1997	19
Mutational Analysis of the CD6 Binding Site in Activated Leukocyte Cell Adhesion Molecule John E. Skonier, Michael A. Bowen, John Emswiler, Biochemistry	1996	16

Page 1